Inflammation-Responsive Nanomaterials for Controlled Drug Release in Obesity-Related Chronic Inflammatory States
2026 | NEWPORT INTERNATIONAL JOURNAL OF SCIENTIFIC AND EXPERIMENTAL SCIENCES (NIJSES) | Pp. 16-22
Obesity is characterized by chronic low-grade inflammation that plays a central role in the development of insulin resistance, type 2 diabetes, cardiovascular disease, and other components of metabolic syndrome. This inflammatory milieu is driven largely by d...